| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Cauwels A | |
| P2860 | cites work | Role of endothelium-derived nitric oxide in the regulation of blood pressure | Q28242958 |
| Calcium-activated potassium channels | Q28278153 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog | Q28320180 | ||
| Involvement of ATP-sensitive potassium channels in a model of a delayed vascular hyporeactivity induced by lipopolysaccharide in rats | Q28343526 | ||
| The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine | Q29547539 | ||
| The epidemiology of sepsis in the United States from 1979 through 2000 | Q29547760 | ||
| Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide | Q29619956 | ||
| P-450 metabolites of arachidonic acid in the control of cardiovascular function | Q29620578 | ||
| Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels | Q33186019 | ||
| Activation of vascular smooth muscle K+ channels by endothelium-derived relaxing factors | Q33538216 | ||
| NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide | Q33575382 | ||
| Biological effects of aminoguanidine: an update | Q33774657 | ||
| Pyridoxalated hemoglobin polyoxyethylene: a nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock | Q33991784 | ||
| Anaphylaxis in the United States: an investigation into its epidemiology | Q34123612 | ||
| Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase | Q34292233 | ||
| The pathogenesis of vasodilatory shock | Q34350541 | ||
| L-canavanine restores blood pressure in a rat model of endotoxic shock. | Q54622387 | ||
| Increasing evidence that the risks of rhAPC may outweigh its benefits. | Q55043389 | ||
| Blood Flow Regulation by S-Nitrosohemoglobin in the Physiological Oxygen Gradient | Q58641869 | ||
| Evidence That Humans Produce Less Nitric Oxide Than Experimental Animals in Septic Shock | Q60456571 | ||
| Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine | Q67537698 | ||
| NG-monomethyl-l-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock | Q67945286 | ||
| Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical | Q69908799 | ||
| Nitric oxide synthase inhibition is detrimental to cardiac function and promotes bronchospasm in anaphylaxis in rabbits | Q71580286 | ||
| Effects of a nitric oxide synthase inhibitor in humans with septic shock | Q71611483 | ||
| Role of nitric oxide in recombinant tumor necrosis factor-alpha-induced circulatory shock: a study in patients treated for cancer with isolated limb perfusion | Q71775893 | ||
| Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity | Q72102328 | ||
| cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells | Q72848651 | ||
| Effects of carboxy-PTIO on systemic hemodynamics, liver energetics, and concentration of liver metabolites during endotoxic shock in rabbits: a 31P and 1H magnetic resonance spectroscopic study | Q73454343 | ||
| Nitric oxide reaction with lipid peroxyl radicals spares alpha-tocopherol during lipid peroxidation. Greater oxidant protection from the pair nitric oxide/alpha-tocopherol than alpha-tocopherol/ascorbate | Q73643093 | ||
| Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock | Q74005713 | ||
| Selective NOS inhibition restores myocardial contractility in endotoxemic rats; however, myocardial NO content does not correlate with myocardial dysfunction | Q74025520 | ||
| Inducible nitric oxide synthase (iNOS) in endotoxemia: chimeric mice reveal different cellular sources in various tissues | Q74211165 | ||
| Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study | Q74480713 | ||
| The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation | Q78038211 | ||
| Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets | Q81243805 | ||
| Septic shock | Q81245367 | ||
| Potassium channels and septic shock | Q82893241 | ||
| Is nitric oxide overproduction the target of choice for the management of septic shock? | Q34463493 | ||
| Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat. | Q34793248 | ||
| Anaphylaxis: a review of causes and mechanisms | Q34810093 | ||
| cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. | Q34831503 | ||
| Anaphylactic shock depends on PI3K and eNOS-derived NO. | Q34872991 | ||
| Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase | Q35026148 | ||
| Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation | Q35052426 | ||
| Novel strategies for the treatment of sepsis | Q35118750 | ||
| Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia | Q35545028 | ||
| Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock | Q35621102 | ||
| Endothelium-derived reactive oxygen species: their relationship to endothelium-dependent hyperpolarization and vascular tone. | Q35626892 | ||
| EDHF: new therapeutic targets? | Q35693574 | ||
| Immune cells: free radicals and antioxidants in sepsis. | Q35705224 | ||
| Acute renal failure and sepsis | Q35833149 | ||
| MaxiK channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms | Q36012140 | ||
| Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide | Q36041762 | ||
| NO generation from nitrite and its role in vascular control | Q36061188 | ||
| Novel therapies for sepsis: a review | Q36095713 | ||
| cGMP-dependent protein kinases in drug discovery | Q36127830 | ||
| Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis | Q36178088 | ||
| Nitric oxide as a modulator of apoptosis | Q36187401 | ||
| N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin | Q36231861 | ||
| Hydrogen sulfide as a vasodilator | Q36276376 | ||
| Signaling for contraction and relaxation in smooth muscle of the gut. | Q36387902 | ||
| Endothelium-derived hyperpolarizing factor: where are we now? | Q36423629 | ||
| Severe sepsis and septic shock: review of the literature and emergency department management guidelines. | Q36510126 | ||
| Role of KATP channels in sepsis | Q36590110 | ||
| Therapeutic use of nitric oxide scavengers in shock and sepsis | Q36612099 | ||
| Survival of TNF toxicity: dependence on caspases and NO. | Q36744895 | ||
| Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin | Q37159291 | ||
| Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide | Q37555750 | ||
| Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein | Q37587741 | ||
| cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. | Q37718172 | ||
| On the expression of nitric oxide synthase by human macrophages. Why no NO? | Q40382556 | ||
| Human monocytes/macrophages: NO or no NO? | Q40752174 | ||
| Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis | Q41021039 | ||
| Role of SK(Ca) and IK(Ca) in endothelium-dependent hyperpolarizations of the guinea-pig isolated carotid artery | Q42131226 | ||
| Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock | Q42150089 | ||
| Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. | Q42484284 | ||
| EDHF and endothelial potassiun channels: IKCa and SKCa | Q43178704 | ||
| Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis | Q43540421 | ||
| The selective guanylate cyclase inhibitor ODQ reduces multiple organ injury in rodent models of Gram-positive and Gram-negative shock | Q43707175 | ||
| Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study | Q43757721 | ||
| Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep | Q43817592 | ||
| Differential involvement of guanylate cyclase and potassium channels in nitric oxide-induced hyporesponsiveness to phenylephrine in endotoxemic rats | Q43857378 | ||
| Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo | Q44121526 | ||
| Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? | Q44190542 | ||
| Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in brown norway rats anaphylactic shock | Q44296580 | ||
| Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. | Q44315300 | ||
| Differential effects of a selective inhibitor of soluble guanylyl cyclase on global and regional hemodynamics during canine endotoxic shock | Q44618408 | ||
| S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide | Q45111036 | ||
| Effect of potassium channel and cytochrome P450 inhibition on transient hypotension and survival during lipopolysaccharide-induced endotoxic shock in the rat. | Q45119665 | ||
| An inhibitor of nitric oxide production, NGnitro-L-arginine-methyl ester, improves survival in anaphylactic shock | Q45180812 | ||
| Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. | Q45256231 | ||
| Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse | Q46465914 | ||
| Dual role of endogenous nitric oxide in tumor necrosis factor shock: induced NO tempers oxidative stress | Q46577764 | ||
| The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. | Q46738154 | ||
| Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse | Q46905143 | ||
| Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock | Q46949999 | ||
| NO contest: nitrite versus S-nitroso-hemoglobin | Q47755076 | ||
| Expression of inducible nitric oxide synthase in circulating neutrophils of the systemic inflammatory response syndrome and septic patients | Q47804605 | ||
| Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. | Q48639311 | ||
| Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock | Q49072068 | ||
| Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase | Q49073437 | ||
| Lethality of endotoxin in mice genetically deficient in the respiratory burst oxidase, inducible nitric oxide synthase, or both | Q50126739 | ||
| Methylene blue: an old-timer or a compound ready for revival? | Q50474866 | ||
| Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock | Q50757928 | ||
| Methylene blue administration in septic shock: a clinical trial. | Q50764693 | ||
| Activation of soluble guanylyl cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin. | Q50772503 | ||
| Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. | Q50773580 | ||
| Inhibition of nitric oxide synthesis by methylene blue | Q50785727 | ||
| Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations | Q50797195 | ||
| Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. | Q50802519 | ||
| Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. | Q51445046 | ||
| Nitric oxide synthase activity is increased in patients with sepsis syndrome. | Q52870839 | ||
| Effects of nitric oxide scavenger, carboxy-PTIO on endotoxin-induced alterations in systemic hemodynamics in rats. | Q54045111 | ||
| NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. | Q54171009 | ||
| Glibenclamide, a blocker of ATP-sensitive potassium channels, reverses endotoxin-induced hypotension in pig. | Q54186651 | ||
| NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? | Q54355366 | ||
| In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia. | Q54459009 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 557-565 | |
| P577 | publication date | 2007-05-30 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Nitric oxide in shock | |
| P478 | volume | 72 |
| Q42209168 | A novel antihypoglycemic role of inducible nitric oxide synthase in liver inflammatory response induced by dietary cholesterol and endotoxemia |
| Q33900988 | A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats |
| Q34069683 | Abandon the mouse research ship? Not just yet! |
| Q46907382 | Abnormal mitochondrial fusion-fission balance contributes to the progression of experimental sepsis |
| Q58064222 | Antihypotensive activity of 2-acetylamino-5,6-dihydro-4H-1,3-thiazine for an endotoxic shock model in rats |
| Q38112398 | Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects |
| Q44107092 | Arginine, citrulline and nitric oxide metabolism in sepsis |
| Q46216898 | Asymmetric dimethylarginine in hematological malignancies: a preliminary study. |
| Q91624079 | Bench to bedside review: therapeutic modulation of nitric oxide in sepsis-an update |
| Q36424922 | Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice |
| Q54567152 | Comparative effects of recombinant human activated protein C and dexamethasone in experimental septic shock. |
| Q40041243 | Comparison of Chemical Profiles, Anti-Inflammatory Activity, and UPLC-Q-TOF/MS-Based Metabolomics in Endotoxic Fever Rats between Synthetic Borneol and Natural Borneol. |
| Q35084210 | Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor, NS-398, on endotoxin-induced hypotension in rats. |
| Q36079408 | Cromoglycate, not ketotifen, ameliorated the injured effect of warm ischemia/reperfusion in rat liver: role of mast cell degranulation, oxidative stress, proinflammatory cytokine, and inducible nitric oxide synthase |
| Q23918584 | Detailed mechanistic investigation into the S-nitrosation of cysteamine |
| Q64996900 | Effects of Inducible Nitric Oxide Synthase Inhibition on Cardiovascular Risk of Adult Endotoxemic Female Rats: Role of Estrogen. |
| Q41820831 | Effects of angiotensin II type 1 receptor antagonist on rats with septic shock. |
| Q33730481 | Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment |
| Q51269085 | Evaluation of the effects of ozone therapy on Escherichia coli-induced cytitis in rat. |
| Q59789259 | Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity |
| Q64070904 | Fusigen Reduces Intracellular Reactive Oxygen Species and Nitric Oxide Levels |
| Q99711537 | HDAC6 Mediates Macrophage iNOS Expression and Excessive Nitric Oxide Production in the Blood During Endotoxemia |
| Q34618265 | Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries |
| Q33745191 | Importance of TLR2 on Hepatic Immune and Non-Immune Cells to Attenuate the Strong Inflammatory Liver Response During Trypanosoma cruzi Acute Infection |
| Q35552149 | Inorganic nitrite therapy: historical perspective and future directions. |
| Q42714463 | Is There NO Treatment For Severe Sepsis? |
| Q58843506 | Kinetics of regulatory dendritic cells in inflammatory responses during Trypanosoma evansi infection |
| Q38577443 | Local and systemic vasodilatory effects of low molecular weight S-nitrosothiols |
| Q37799814 | Mitochondrial protein tyrosine nitration |
| Q46049455 | Mycophenolate mofetil has potent anti-inflammatory actions in a mouse model of acute lung injury |
| Q37174392 | NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite |
| Q58863636 | Nitric Oxide, Oxidative Stress, Immune Response and Critical Care |
| Q38935631 | Nitric oxide inhibition strategies |
| Q36596738 | Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock |
| Q33590497 | Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner |
| Q37796480 | Nitrite regulation of shock |
| Q37367885 | Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response |
| Q38018000 | Novel targets for sepsis-induced kidney injury: the glomerular arterioles and the sympathetic nervous system. |
| Q42566525 | Of mice, men, and inflammation |
| Q50542506 | Oral Nitrate Increases Microvascular Reactivity and the Number of Visible Perfused Microvessels in Healthy Volunteers. |
| Q36583958 | Oxidative Stress in Critically Ill Children with Sepsis |
| Q37579737 | Oxidative mechanisms of brain dysfunction during sepsis |
| Q45966408 | Ozone oxidative preconditioning reduces nitrite levels in blood serum in LPS: induced endotoxic shock in mice. |
| Q35173157 | Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide |
| Q46093946 | Preconditioning with ozone/oxygen mixture induces reversion of some indicators of oxidative stress and prevents organic damage in rats with fecal peritonitis |
| Q37108130 | Protective effects of Sparstolonin B, a selective TLR2 and TLR4 antagonist, on mouse endotoxin shock |
| Q34063569 | Reactive oxygen species and small-conductance calcium-dependent potassium channels are key mediators of inflammation-induced hypotension and shock |
| Q51516632 | S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism. |
| Q55347703 | Skin microcirculatory reactivity assessed using a thermal challenge is decreased in patients with circulatory shock and associated with outcome. |
| Q82059168 | Temporal trends of circulating nitric oxide and pro-inflammatory cytokine responses ex vivo in intra-abdominal sepsis: results from a cohort study |
| Q37187567 | The neutrophil elastase inhibitor, sivelestat, attenuates sepsis-related kidney injury in rats |
| Q34153194 | Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model |
| Q36871040 | Two N-(2-phenylethyl)nitroaniline derivatives as precursors for slow and sustained nitric oxide release agents |
| Q37791460 | Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside |
| Q37298332 | sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models. |
Search more.